Large-scale clinical COVID-19 vaccine trials intentionally excluded pregnant women, leaving them to wonder whether to get the shots or not.
Author: Karen Weintraub, USA TODAY
COVID-19 vaccine from AstraZeneca-Oxford slightly less effective than first touted: 76% rather than 79% against disease, updated data shows
More recent clinical trial results show AstraZeneca’s COVID-19 vaccine is slightly less effective in stopping disease than the company first reported.
Moncef Slaoui, former Operation Warp Speed science chief, fired by drugmaker GSK for sexual harassment
Moncef Slaoui, a former head of Operation Warp Speed, who spearheaded COVID-19 vaccine development in the USA, was fired by GSK for harassing an employee.
FDA advisory committees will begin hearings on drug aimed at osteoarthritis pain
Two FDA advisory committees will begin meeting Wednesday on a Pfizer drug called tanezumab that could bring relief for osteoarthritis pain.
‘It’s easy to scare people’: Europe’s decision to pull AstraZeneca-Oxford vaccine threatens global COVID-19 recovery efforts, US experts say
As AstraZeneca defends its COVID-19 vaccine following a European pause, the World Health Organization says there is no reason to stop using it.
People with immune issues – at ‘high risk’ for COVID-19 – remain hesitant about vaccination. Here’s what experts say
Organizations representing experts in cancer, organ transplantation and autoimmune diseases support COVID-19 vaccination for their patients.
‘It’s like we’re trying our best to help the virus’: A fourth wave is looming if US fails to contain COVID-19 variants, experts say
Health experts urge continued vigilance against the spread of coronavirus variants as some state officials lift mask mandates and ease restrictions.
‘Game changer’ single-dose vaccine from Johnson & Johnson is safe and 66% effective, company says
The one-dose COVID-19 vaccine from J&J is a game changer because of easier and cheaper distribution. A large study has found it safe and effective.
Novavax’s COVID-19 vaccine shown to be nearly 90% effective in UK clinical trial, also provided a range of immunity against new variants
The Novavax vaccine candidate also appears to have mixed levels of effectiveness against coronavirus variants.
The first 22M Americans have been vaccinated for COVID-19, and initial safety data shows everything is going well, CDC says
Side effects remain a common result of both the Pfizer-BioNTech and Moderna vaccines, with 70% of people who self-reported saying they suffered pain.